default author photo

Jiong Hu

Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Hematology

China

SCHOLARLY PAPERS

3

DOWNLOADS

320

TOTAL CITATIONS

1

Scholarly Papers (3)

1.

Effect of rhG-CSF Combined with Decitabine Prophylaxis on Relapse in High-Risk Acute Myeloid Leukemia Patients after Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized, Controlled, Phase 2 Trial

Number of pages: 84 Posted: 02 Dec 2019
Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Army Medical University, Government of the People's Republic of China - General Hospital of Kunming Military Region, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - General Hospital of Kunming Military Region, Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Hematology, Xinjiang Medical University, Government of the People's Republic of China - General Hospital of Lanzhou Military Region, Xinjiang Provincial People's Hospital, Guizhou Medical University (Guiyang Medical University) - Department of Hematology, Government of the People's Republic of China - Tangdu Hospital - Department of Hematology, Government of the People's Republic of China - Yunan Provincial People’s Hospital, Government of the People's Republic of China - Sichuan Provincial People's Hospital, Government of the People's Republic of China - General Hospital of Chengdu Military Region of the PLA, Chongqing Medical University - Second Affiliated Hospital, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Xinjiang Provincial People's Hospital, Government of the People's Republic of China - General Hospital of Lanzhou Military Region, Xinjiang Medical University, Government of the People's Republic of China - General Hospital of Kunming Military Region, Government of the People's Republic of China - Department of Hematology, City of Hope - Beckman Research Institute, Government of the People's Republic of China - Department of Hematology and Government of the People's Republic of China - Medical Center of Hematology
Downloads 129 (561,789)

Abstract:

Loading...

acute myeloid leukemia; high risk; allogeneic hematopoietic stem cell transplantation; decitabine; granulocyte colony-stimulating factor; relapse

2.

Effect of rhG-CSF Combined with Decitabine Prophylaxis on Relapse in High-Risk Acute Myeloid Leukemia Patients after Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized, Controlled, Phase 2 Trial

Number of pages: 84 Posted: 26 Nov 2019
Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - College of Preventive Medicine, Government of the People's Republic of China - General Hospital of Kunming Military Region, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - General Hospital of Kunming Military Region, Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Hematology, Xinjiang Medical University, Government of the People's Republic of China - General Hospital of Lanzhou Military Region, Xinjiang Provincial People's Hospital, Guizhou Medical University (Guiyang Medical University) - Department of Hematology, Government of the People's Republic of China - Tangdu Hospital, Government of the People's Republic of China - Yunan Provincial People’s Hospital, Government of the People's Republic of China - Sichuan Provincial People's Hospital, Government of the People's Republic of China - General Hospital of Chengdu Military Region of the PLA, Chongqing Medical University - Second Affiliated Hospital, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Xinjiang Provincial People's Hospital, Government of the People's Republic of China - General Hospital of Lanzhou Military Region, Xinjiang Medical University, Government of the People's Republic of China - General Hospital of Kunming Military Region, Government of the People's Republic of China - Department of Hematology, City of Hope - Beckman Research Institute, Government of the People's Republic of China - Department of Hematology and Government of the People's Republic of China - Medical Center of Hematology
Downloads 119 (600,462)

Abstract:

Loading...

acute myeloid leukemia; high risk; allogeneic hematopoietic stem cell transplantation; decitabine; granulocyte colony-stimulating factor; relapse

3.

CAG Regimen for Refractory or Relapsed Adult T-Cell Acute Lymphoblastic Leukemia: A Retrospective, Multicenter, Cohort Study

Number of pages: 28 Posted: 21 Sep 2019
Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Government of the People's Republic of China - Department of Hematology, Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Hematology, Government of the People's Republic of China - Changzheng Hospital, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Shulan (Hangzhou) Hospital, Government of the People's Republic of China - Department of Hematology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Shaoxing Central Hospital, Peking University, Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Hematology, Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Hematology, Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Hematology, Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Hematology and Zhejiang University - Department of Hematology
Downloads 72 (860,052)
Citation 1

Abstract:

Loading...

T-cell acute lymphoblastic leukemia; refractory or relapse; stem cell transplantation